AiRuiLi (adebrelimab)

Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone (clinicaltrials.gov)

A Single-Arm, Exploratory Clinical Study of Irinotecan Liposome (II) in Combination with Adebrelimab for Platinum-Resistant Recurrent Ovarian Cancer (ChiCTR2600117530)

Efficacy and safety of doxorubicin liposomal and adebrelimab in the treatment of osteosarcoma failed standard treatment: a multicenter, interventional clinical study (ChiCTR2600115969)

A single-arm, multicenter, prospective clinical study on neoadjuvant therapy of elderly patients with advanced esophageal squamous cell carcinoma using adebrelimab combined with albumin-paclitaxel (ChiCTR2500113913)

Trastuzumab rezetecan alone or in combination with adebrelimab in advanced solid tumors with HER2 expression or mutation: a prospective, multicenter, open, nonrandomized, multicohort study. (ChiCTR2500113763)

An Exploratory Clinical Study of Adebrelimab Combined with Apatinib and Chemotherapy as Neoadjuvant Therapy for Initially Unresectable Stage III Non-Small Cell Lung Cancer (ChiCTR2500113380)

NIOFA-02: A Randomized, Open-Label Cohort Study of Adebrelimab Combined with NALIRIFOX or Gemcitabine-Cisplatin (GC) as First-Line Treatment for Locally Advanced or Metastatic Biliary Tract Cancer (ChiCTR2600116738)

A prospective clinical study of Adebrelimab combined with chemotherapy and brain radiotherapy as the first-line treatment for extensive-stage small cell lung cancer with brain metastases (ChiCTR2600116872)

Exploratory clinical study on preserving organs in patients with stage II-III non-small cell lung cancer(The Future Star) (ChiCTR2500115167)

Adebrelimab and famitinib alone or combined with short-course chemotherapy as the first-line treatment for PD-L1-positive advanced non-small cell lung cancer: a clinical study (ChiCTR2500115247)

Disitamab Vedotin and Adebrelimab in combination with SOX in the perioperative treatment of HER2-expressing Locally Advanced Esophageal Adenocarcinoma and Esophagogastric Junction Adenocarcinoma: A Prospective, Single-Arm Phase II Study (ChiCTR2500115516)

A single-center, open-label, Phase II study of Adebrelimab Injection in combination with albumin-paclitaxel and cisplatin for neoadjuvant treatment of resectable oral squamous cell carcinoma (ChiCTR2500115521)